Molinaro A, Braadland PR, Carpino G, Carreras A, Nikolaidis M, Hanzely P, Beck KR, Ali AH, Bossen L, Frank A, Lundqvist A, Juran BD, Overi D, Geng L, Amundsen-Isaksen E, Reims HM, Björk I, Grzyb K, Abildgaard A, Folseraas T, Cornillet M, Helgadóttir H, McCauley BM, Cristoferi L, Carbone M, Cardinale V, Høivik ML, Engesæter LK, Tjønnfjord SKV, McCann A et al. (2026)
Gut microbiota-derived imidazole propionate promotes primary sclerosing cholangitis via p38 signalling
Nat Metab (in press)
DOI 10.1038/s42255-026-01600-1, PubMed 42698000

Iversen PO, Holm K, Bang C, Tjønnfjord GE, Gedde-Dahl T, Ali MM, Hov JR (2026)
Extracorporeal photopheresis as GVHD prophylaxis: No impact on gut microbiota-a randomized controlled trial
Br J Haematol (in press)
DOI 10.1111/bjh.70831, PubMed 42687407

Maseng MG, Hansen SH, Grännö O, Bang C, Lund C, Huppertz-Hauss G, Perminow G, Valeur J, Bengtson MB, Opheim R, Boyar R, Frigstad SO, Aabrekk TB, Detlie TE, Kristensen VA, Strande V, Hovde Ø, Asak Ø, Franke A, Halfvarsson J, Høivik ML, Hov JR (2026)
Disentangling the gut microbiome and inflammation in inflammatory bowel diseases: longitudinal observations from the IBSEN III study
Inflamm Bowel Dis, 32 (9), 1695-1706
DOI 10.1093/ibd/izag051, PubMed 41966990